CoChat
Sign Up
Cited by 108

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution

Ratcliff, Jeremy, Simmonds, Peter·2021·Virology
DOI 10.1016/j.virol.2020.12.018PMC PMC7831814
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.virol.2020.12.018

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 7 references

Research works printed but not linked: 152

  1. Anwar, 2013, Footprint of APOBEC3 on the genome of human retroelements, J. Virol., 87, 8195, 10.1128/JVI.00298-13 · DOI
  2. Aydin, 2014, Structure-guided analysis of the human APOBEC3-HIV restrictome, Structure, 22, 668, 10.1016/j.str.2014.02.011 · DOI
  3. Backus, 1991, Apolipoprotein B mRNA sequences 3' of the editing site are necessary and sufficient for editing and editosome assembly, Nucleic Acids Res., 19, 6781, 10.1093/nar/19.24.6781 · DOI
  4. Baker, 2013, Antiviral immune responses of bats: a review, Zoonoses and public health, 60, 104, 10.1111/j.1863-2378.2012.01528.x · DOI
  5. Berkhout, 2015, On the biased nucleotide composition of the human coronavirus RNA genome, Virus Res., 202, 41, 10.1016/j.virusres.2014.11.031 · DOI
  6. Biémont, 2006, Genetics: junk DNA as an evolutionary force, Nature, 443, 521, 10.1038/443521a · DOI
  7. Bishop, 2004, APOBEC-mediated editing of viral RNA, Science, 305, 645, 10.1126/science.1100658 · DOI
  8. Blanc, 2014, Genome-wide identification and functional analysis of Apobec-1-mediated C-to-U RNA editing in mouse small intestine and liver, Genome Biol., 15, R79, 10.1186/gb-2014-15-6-r79 · DOI
  9. Blanco-Melo, 2020, Imbalanced host response to SARS-CoV-2 drives development of COVID-19, Cell, 181, 1036, 10.1016/j.cell.2020.04.026 · DOI · Paper page
  10. Boeke, 1985, Ty elements transpose through an RNA intermediate, Cell, 40, 491, 10.1016/0092-8674(85)90197-7 · DOI
  11. Bourque, 2018, Ten things you should know about transposable elements, Genome Biol., 19, 199, 10.1186/s13059-018-1577-z · DOI · Paper page
  12. Brouha, 2003, Hot L1s account for the bulk of retrotransposition in the human population, Proc. Natl. Acad. Sci. U. S. A., 100, 5280, 10.1073/pnas.0831042100 · DOI · Paper page
  13. Burns, 2015, APOBEC3B: pathological consequences of an innate immune DNA mutator, Biomed. J., 38, 102, 10.4103/2319-4170.148904 · DOI
  14. Chan, 2015, An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers, Nat. Genet., 47, 1067, 10.1038/ng.3378 · DOI · Paper page
  15. Chaudhuri, 2003, Transcription-targeted DNA deamination by the AID antibody diversification enzyme, Nature, 422, 726, 10.1038/nature01574 · DOI
  16. Chen, 2006, APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Current biology, CB, 16, 480
  17. Chen, 1987, Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon, Science, 238, 363, 10.1126/science.3659919 · DOI
  18. Conticello, 2003, The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G, Curr. Biol. : CB, 13, 2009, 10.1016/j.cub.2003.10.034 · DOI
  19. Conticello, 2005, Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases, Mol. Biol. Evol., 22, 367, 10.1093/molbev/msi026 · DOI
  20. Corman, 2018, Hosts and sources of endemic human coronaviruses, Adv. Virus Res., 100, 163, 10.1016/bs.aivir.2018.01.001 · DOI
  21. Davidson, 1995, Proposed nomenclature for the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme: APOBEC-1, Rna, 1, 3
  22. Delviks-Frankenberry, 2020, Structural insights into APOBEC3-mediated lentiviral restriction, Viruses, 12, 10.3390/v12060587 · DOI
  23. Derse, 2007, Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid, Proc. Natl. Acad. Sci. U. S. A., 104, 2915, 10.1073/pnas.0609444104 · DOI
  24. Desimmie, 2014, Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all, J. Mol. Biol., 426, 1220, 10.1016/j.jmb.2013.10.033 · DOI
  25. Di Giorgio, 2020, Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2, Sci. Advances, 10.1126/sciadv.abb5813 · DOI · Paper page
  26. Dickerson, 2003, AID mediates hypermutation by deaminating single stranded DNA, J. Exp. Med., 197, 1291, 10.1084/jem.20030481 · DOI
  27. Eckerle, 2010, Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing, PLoS Pathog., 6, 10.1371/journal.ppat.1000896 · DOI
  28. Eckerle, 2007, High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants, J. Virol., 81, 12135, 10.1128/JVI.01296-07 · DOI
  29. Endo, 2007, Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling, Oncogene, 26, 5587, 10.1038/sj.onc.1210344 · DOI
  30. Etard, 2010, Lack of Apobec2-related proteins causes a dystrophic muscle phenotype in zebrafish embryos, J. Cell Biol., 189, 527, 10.1083/jcb.200912125 · DOI
  31. Fehrholz, 2012, The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses, J. Gen. Virol., 93, 565, 10.1099/vir.0.038919-0 · DOI
  32. Flajnik, 2010, Origin and evolution of the adaptive immune system: genetic events and selective pressures. Nature reviews, Genetics, 11, 47
  33. Fossat, 2014, C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47, EMBO Rep., 15, 903, 10.15252/embr.201438450 · DOI · Paper page
  34. Fribourgh, 2014, Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase, J. Virol., 88, 3309, 10.1128/JVI.03824-13 · DOI
  35. Gaunt, 2010, Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method, J. Clin. Microbiol., 48, 2940, 10.1128/JCM.00636-10 · DOI
  36. Gerber, 2001, RNA editing by base deamination: more enzymes, more targets, new mysteries, Trends Biochem. Sci., 26, 376, 10.1016/S0968-0004(01)01827-8 · DOI
  37. Gonzalez, 2009, Human APOBEC1 cytidine deaminase edits HBV DNA, Retrovirology, 6, 96, 10.1186/1742-4690-6-96 · DOI
  38. Green, 2016, APOBEC3A damages the cellular genome during DNA replication, Cell Cycle, 15, 998, 10.1080/15384101.2016.1152426 · DOI
  39. Haché, 2006, Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance, AIDS Rev., 8, 148
  40. Hamre, 1966, A new virus isolated from the human respiratory tract, Proc Soc Exp Biol Med, 121, 190, 10.3181/00379727-121-30734 · DOI
  41. Harari, 2009, Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H, J. Virol., 83, 295, 10.1128/JVI.01665-08 · DOI
  42. Harris, 2015, APOBECs and virus restriction, Virology, 479–480, 131, 10.1016/j.virol.2015.03.012 · DOI · Paper page
  43. Hayward, 2018, Differential evolution of antiretroviral restriction factors in pteropid bats as revealed by APOBEC3 gene complexity, Mol. Biol. Evol., 35, 1626, 10.1093/molbev/msy048 · DOI
  44. Henderson, 2015, APOBEC3 genes: retroviral restriction factors to cancer drivers, Trends Mol. Med., 21, 274, 10.1016/j.molmed.2015.02.007 · DOI
  45. Hsu, 2016, Assembly and expression of shark ig genes, J. Immunol., 196, 3517, 10.4049/jimmunol.1600164 · DOI
  46. Ikeda, 2011, Intrinsic restriction activity by apolipoprotein B mRNA editing enzyme APOBEC1 against the mobility of autonomous retrotransposons, Nucleic Acids Res., 39, 5538, 10.1093/nar/gkr124 · DOI
  47. Ito, 2020, Retroviruses drive the rapid evolution of mammalian APOBEC3 genes, Proc. Natl. Acad. Sci. U. S. A., 117, 610, 10.1073/pnas.1914183116 · DOI
  48. Iyer, 2011, Evolution of the deaminase fold and multiple origins of eukaryotic editing and mutagenic nucleic acid deaminases from bacterial toxin systems, Nucleic Acids Res., 39, 9473, 10.1093/nar/gkr691 · DOI
  49. Jaguva Vasudevan, 2013, Prototype foamy virus Bet impairs the dimerization and cytosolic solubility of human APOBEC3G, J. Virol., 87, 9030, 10.1128/JVI.03385-12 · DOI
  50. Janini, 2001, Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells, J. Virol., 75, 7973, 10.1128/JVI.75.17.7973-7986.2001 · DOI
  51. Jarmuz, 2002, An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22, Genomics, 79, 285, 10.1006/geno.2002.6718 · DOI
  52. Kaiser, 2006, Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G, J. Virol., 80, 875, 10.1128/JVI.80.2.875-882.2006 · DOI
  53. Kao, 2003, The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity, J. Virol., 77, 11398, 10.1128/JVI.77.21.11398-11407.2003 · DOI
  54. Kieffer, 2005, G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo, J. Virol., 79, 1975, 10.1128/JVI.79.3.1975-1980.2005 · DOI
  55. Klimczak, 2020, Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic, PloS One, 15, 10.1371/journal.pone.0237689 · DOI · Paper page
  56. Kremer, 2006, Vaccinia virus replication is not affected by APOBEC3 family members, Virol. J., 3, 86, 10.1186/1743-422X-3-86 · DOI
  57. Krishnan, 2018, Diversification of AID/APOBEC-like deaminases in metazoa: multiplicity of clades and widespread roles in immunity, Proc. Natl. Acad. Sci. U. S. A., 115, E3201, 10.1073/pnas.1720897115 · DOI
  58. Kristbjörnsdóttir, 2004, The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro, Virology, 318, 350, 10.1016/j.virol.2003.09.044 · DOI
  59. Ksiazek, 2003, A novel coronavirus associated with severe acute respiratory syndrome, N. Engl. J. Med., 348, 1953, 10.1056/NEJMoa030781 · DOI
  60. Lander, 2001, Initial sequencing and analysis of the human genome, Nature, 409, 860, 10.1038/35057062 · DOI · Paper page
  61. Langlois, 2008, Human APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1, J. Virol., 82, 4660, 10.1128/JVI.02469-07 · DOI
  62. LaRue, 2009, Guidelines for naming nonprimate APOBEC3 genes and proteins, J. Virol., 83, 494, 10.1128/JVI.01976-08 · DOI
  63. LaRue, 2008, The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals, BMC Mol. Biol., 9, 104, 10.1186/1471-2199-9-104 · DOI
  64. Lee, 1998, An alternatively spliced form of apobec-1 messenger RNA is overexpressed in human colon cancer, Gastroenterology, 115, 1096, 10.1016/S0016-5085(98)70080-0 · DOI
  65. Li, 2018, Enterovirus 71 antagonizes the inhibition of the host intrinsic antiviral factor A3G, Nucleic Acids Res., 46, 11514, 10.1093/nar/gky840 · DOI
  66. Liang, 2013, RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase, Proc. Natl. Acad. Sci. U. S. A., 110, 2246, 10.1073/pnas.1221921110 · DOI
  67. Liao, 2020, Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19, Nat. Med., 26, 842, 10.1038/s41591-020-0901-9 · DOI · Paper page
  68. Liao, 1999, APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family, Biochem. Biophys. Res. Commun., 260, 398, 10.1006/bbrc.1999.0925 · DOI
  69. Liu, 2018, AID/APOBEC-like cytidine deaminases are ancient innate immune mediators in invertebrates, Nat. Commun., 9, 1948, 10.1038/s41467-018-04273-x · DOI
  70. Löchelt, 2005, The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein, Proc. Natl. Acad. Sci. U. S. A., 102, 7982, 10.1073/pnas.0501445102 · DOI
  71. MacDuff, 2009, AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity, Nucleic Acids Res., 37, 1854, 10.1093/nar/gkp030 · DOI
  72. Marin, 2003, HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation, Nat. Med., 9, 1398, 10.1038/nm946 · DOI
  73. McDaniel, 2020, Deamination hotspots among APOBEC3 family members are defined by both target site sequence context and ssDNA secondary structure, Nucleic Acids Res., 48, 1353, 10.1093/nar/gkz1164 · DOI
  74. McIntosh, 1967, Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease, Proc. Natl. Acad. Sci. U. S. A., 58, 2268, 10.1073/pnas.58.6.2268 · DOI
  75. Mehle, 2004, Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation, Genes Dev., 18, 2861, 10.1101/gad.1249904 · DOI
  76. Mehle, 2004, Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway, J. Biol. Chem., 279, 7792, 10.1074/jbc.M313093200 · DOI
  77. Mehta, 2000, Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA, Mol. Cell Biol., 20, 1846, 10.1128/MCB.20.5.1846-1854.2000 · DOI
  78. Mikkelsen, 2007, Genome of the marsupial Monodelphis domestica reveals innovation in non-coding sequences, Nature, 447, 167, 10.1038/nature05805 · DOI · Paper page
  79. Milewska, 2018, APOBEC3-mediated restriction of RNA virus replication, Sci. Rep., 8, 5960, 10.1038/s41598-018-24448-2 · DOI
  80. Moris, 2014, AID and APOBECs span the gap between innate and adaptive immunity, Front. Microbiol., 5, 534, 10.3389/fmicb.2014.00534 · DOI
  81. Munk, 2012, An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammals, BMC Evol. Biol., 12, 71, 10.1186/1471-2148-12-71 · DOI
  82. Muramatsu, 2000, Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme, Cell, 102, 553, 10.1016/S0092-8674(00)00078-7 · DOI
  83. Muramatsu, 1999, Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells, J. Biol. Chem., 274, 18470, 10.1074/jbc.274.26.18470 · DOI
  84. Nakano, 2017, A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif, Retrovirology, 14, 31, 10.1186/s12977-017-0355-4 · DOI
  85. Narvaiza, 2009, Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase, PLoS Pathog., 5, 10.1371/journal.ppat.1000439 · DOI
  86. Okuyama, 2012, Excessive activity of apolipoprotein B mRNA editing enzyme catalytic polypeptide 2 (APOBEC2) contributes to liver and lung tumorigenesis, Int. J. Canc., 130, 1294, 10.1002/ijc.26114 · DOI
  87. Ostertag, 2001, Biology of mammalian L1 retrotransposons, Annu. Rev. Genet., 35, 501, 10.1146/annurev.genet.35.102401.091032 · DOI
  88. Oude Munnink, 2021, Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans, Science, 371, 172, 10.1126/science.abe5901 · DOI
  89. Pauli, 2009, High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity, Retrovirology, 6, 38, 10.1186/1742-4690-6-38 · DOI
  90. Perelygina, 2019, Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies, PLoS Pathog., 15, e1008080, 10.1371/journal.ppat.1008080 · DOI · Paper page
  91. Pham, 2003, Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation, Nature, 424, 103, 10.1038/nature01760 · DOI
  92. Pizarro, 2016, Post-transcriptional control of LINE-1 retrotransposition by cellular host factors in somatic cells, Front Cell Dev Biol, 4, 14, 10.3389/fcell.2016.00014 · DOI
  93. Poulain, 2020, Footprint of the host restriction factors APOBEC3 on the genome of human viruses, PLoS Pathog., 16, 10.1371/journal.ppat.1008718 · DOI
  94. Powell, 1987, A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine, Cell, 50, 831, 10.1016/0092-8674(87)90510-1 · DOI
  95. Renard, 2010, APOBEC1 and APOBEC3 cytidine deaminases as restriction factors for hepadnaviral genomes in non-humans in vivo, J. Mol. Biol., 400, 323, 10.1016/j.jmb.2010.05.029 · DOI
  96. Richardson, 2015, The influence of LINE-1 and SINE retrotransposons on mammalian genomes, Microbiol. Spectr., 3, 10.1128/microbiolspec.MDNA3-0061-2014 · DOI
  97. Richardson, 2014, APOBEC3A deaminates transiently exposed single-strand DNA during LINE-1 retrotransposition, Elife, 3, 10.7554/eLife.02008 · DOI
  98. Roberts, 2013, An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers, Nat. Genet., 45, 970, 10.1038/ng.2702 · DOI
  99. Rogozin, 2005, APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis, Cell Cycle, 4, 1281, 10.4161/cc.4.9.1994 · DOI
  100. Rogozin, 2007, Evolution and diversification of lamprey antigen receptors: evidence for involvement of an AID-APOBEC family cytosine deaminase, Nat. Immunol., 8, 647, 10.1038/ni1463 · DOI
  101. Rosenberg, 2011, Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3' UTRs, Nat. Struct. Mol. Biol., 18, 230, 10.1038/nsmb.1975 · DOI · Paper page
  102. Rubin, 1982, The molecular basis of P-M hybrid dysgenesis: the nature of induced mutations, Cell, 29, 987, 10.1016/0092-8674(82)90462-7 · DOI
  103. Russell, 2005, Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors, J. Virol., 79, 8724, 10.1128/JVI.79.14.8724-8731.2005 · DOI
  104. Salter, 2016, The APOBEC protein family: united by structure, divergent in function, Trends Biochem. Sci., 41, 578, 10.1016/j.tibs.2016.05.001 · DOI · Paper page
  105. Sato, 2010, Deficiency in APOBEC2 leads to a shift in muscle fiber type, diminished body mass, and myopathy, J. Biol. Chem., 285, 7111, 10.1074/jbc.M109.052977 · DOI
  106. Schumann, 2007, APOBEC3 proteins: major players in intracellular defence against LINE-1-mediated retrotransposition, Biochem. Soc. Trans., 35, 637, 10.1042/BST0350637 · DOI
  107. Seeger, 2000, Hepatitis B virus biology, Microbiol. Mol. Biol. Rev., 64, 51, 10.1128/MMBR.64.1.51-68.2000 · DOI
  108. Sharma, 2016, The double-domain cytidine deaminase APOBEC3G is a cellular site-specific RNA editing enzyme, Sci. Rep., 6, 39100, 10.1038/srep39100 · DOI · Paper page
  109. Sharma, 2015, APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages, Nat. Commun., 6, 6881, 10.1038/ncomms7881 · DOI · Paper page
  110. Sharma, 2019, Mitochondrial hypoxic stress induces widespread RNA editing by APOBEC3G in natural killer cells, Genome Biol., 20, 37, 10.1186/s13059-019-1651-1 · DOI
  111. Sheehy, 2002, Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein, Nature, 418, 646, 10.1038/nature00939 · DOI
  112. Sheehy, 2003, The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif, Nat. Med., 9, 1404, 10.1038/nm945 · DOI
  113. Shi, 2020, Characterization and functional analysis of chicken APOBEC4, Dev. Comp. Immunol., 106, 103631, 10.1016/j.dci.2020.103631 · DOI
  114. Simmonds, 2020, Pervasive RNA secondary structure in the genomes of SARS-CoV-2 and other coronaviruses, mBio, 11, 10.1128/mBio.01661-20 · DOI
  115. Simmonds, 2020, Rampant C→U hypermutation in the genomes of SARS-CoV-2 and other coronaviruses: causes and consequences for their short- and long-term evolutionary trajectories, mSphere, 5, 10.1128/mSphere.00408-20 · DOI · Paper page
  116. Skuse, 1996, The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing, Nucleic Acids Res., 24, 478, 10.1093/nar/24.3.478 · DOI
  117. Smith, 2013, Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics, PLoS Pathog., 9, 10.1371/journal.ppat.1003565 · DOI
  118. Smith, 2017, RNA binding to APOBEC deaminases; Not simply a substrate for C to U editing, RNA Biol., 14, 1153, 10.1080/15476286.2016.1259783 · DOI
  119. Stenglein, 2006, APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism, J. Biol. Chem., 281, 16837, 10.1074/jbc.M602367200 · DOI
  120. Stopak, 2003, HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability, Mol. Cell, 12, 591, 10.1016/S1097-2765(03)00353-8 · DOI
  121. Suspène, 2011, Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo, J. Virol., 85, 7594, 10.1128/JVI.00290-11 · DOI
  122. Suspène, 2005, Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo, Proc. Natl. Acad. Sci. U. S. A., 102, 8321, 10.1073/pnas.0408223102 · DOI
  123. Taylor, 2013, DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis, Elife, 2, 10.7554/eLife.00534 · DOI
  124. Teng, 1993, Molecular cloning of an apolipoprotein B messenger RNA editing protein, Science, 260, 1816, 10.1126/science.8511591 · DOI · Paper page
  125. Tsuge, 2010, G to A hypermutation of TT virus, Virus Res., 149, 211, 10.1016/j.virusres.2010.01.019 · DOI
  126. Uhlén, 2015, Proteomics. Tissue-based map of the human proteome, Science, 347, 1260419, 10.1126/science.1260419 · DOI · Paper page
  127. van der Hoek, 2004, Identification of a new human coronavirus, Nat. Med., 10, 368, 10.1038/nm1024 · DOI
  128. van Dorp, 2020, Emergence of genomic diversity and recurrent mutations in SARS-CoV-2, Infect. Genet. Evol.: journal of molecular epidemiology and evolutionary genetics in infectious diseases, 83, 104351, 10.1016/j.meegid.2020.104351 · DOI
  129. van Maldegem, 2009, AID splice variants lack deaminase activity, Blood, 113, 1862, 10.1182/blood-2008-08-175265 · DOI
  130. Vartanian, 2008, Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions, Science, 320, 230, 10.1126/science.1153201 · DOI
  131. Vonica, 2011, APOBEC2, a selective inhibitor of TGFβ signaling, regulates left-right axis specification during early embryogenesis, Dev. Biol., 350, 13, 10.1016/j.ydbio.2010.09.016 · DOI
  132. Wang, 2018, Simian immunodeficiency virus vif and human APOBEC3B interactions resemble those between HIV-1 vif and human APOBEC3G, J. Virol., 92, 10.1128/JVI.00447-18 · DOI
  133. Wang, 2009, APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein, Virology, 388, 112, 10.1016/j.virol.2009.03.010 · DOI
  134. Warren, 2015, Role of the host restriction factor APOBEC3 on papillomavirus evolution, Virus evolution, 1, 10.1093/ve/vev015 · DOI
  135. Warren, 2015, APOBEC3A functions as a restriction factor of human papillomavirus, J. Virol., 89, 688, 10.1128/JVI.02383-14 · DOI
  136. Weil, 2013, Uracil DNA glycosylase initiates degradation of HIV-1 cDNA containing misincorporated dUTP and prevents viral integration, Proc. Natl. Acad. Sci. U. S. A., 110, E448, 10.1073/pnas.1219702110 · DOI
  137. Woo, 2005, Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia, J. Virol., 79, 884, 10.1128/JVI.79.2.884-895.2005 · DOI
  138. Woo, 2007, Cytosine deamination and selection of CpG suppressed clones are the two major independent biological forces that shape codon usage bias in coronaviruses, Virology, 369, 431, 10.1016/j.virol.2007.08.010 · DOI
  139. Wu, 2020, A new coronavirus associated with human respiratory disease in China, Nature, 579, 265, 10.1038/s41586-020-2008-3 · DOI · Paper page
  140. Xu, 2020, The role of APOBECs in viral replication, Microorganisms, 8, 10.3390/microorganisms8121899 · DOI
  141. Yamanaka, 1995, Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals, Proc. Natl. Acad. Sci. U. S. A., 92, 8483, 10.1073/pnas.92.18.8483 · DOI
  142. Yamanaka, 1997, A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme, Genes Dev., 11, 321, 10.1101/gad.11.3.321 · DOI
  143. Yang, 2007, Virion-associated uracil DNA glycosylase-2 and apurinic/apyrimidinic endonuclease are involved in the degradation of APOBEC3G-edited nascent HIV-1 DNA, J. Biol. Chem., 282, 11667, 10.1074/jbc.M606864200 · DOI
  144. Yu, 2003, Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex, Science, 302, 1056, 10.1126/science.1089591 · DOI
  145. Zaki, 2012, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia, N. Engl. J. Med., 367, 1814, 10.1056/NEJMoa1211721 · DOI
  146. Zhang, 2011, T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction, Nature, 481, 376, 10.1038/nature10718 · DOI
  147. Zhang, 2014, Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins, J. Virol., 88, 12528, 10.1128/JVI.02072-14 · DOI
  148. Zhang, 2018, Feline APOBEC3s, barriers to cross-species transmission of FIV?, Viruses, 10, 10.3390/v10040186 · DOI
  149. Zhao, 2019, CAEV vif hijacks ElonginB/C, CYPA and Cullin5 to assemble the E3 ubiquitin ligase complex stepwise to degrade oaA3Z2-Z3, Front. Microbiol., 10, 565, 10.3389/fmicb.2019.00565 · DOI
  150. Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 · DOI · Paper page
  151. Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017 · DOI · Paper page
  152. Zielonka, 2010, Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids, J. Virol., 84, 7312, 10.1128/JVI.00209-10 · DOI

Cited by

Sorted by citations

See all 108

Metadata

Authors
Ratcliff, J., & Simmonds, P.
ORCID
Ratcliff, Jeremy
Venue
Virology
Publisher
Elsevier BV
Published
2021-04
Volume
556
Pages
62-72
ISSN
0042-6822
DOI
10.1016/j.virol.2020.12.018
PMC
PMC7831814
Cited by
108
References
7
Language
en
Licence
Funders
Wellcome Trust

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review